找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P; Vikas Prasad Book‘‘‘‘‘‘‘‘ 2024 The E

[復制鏈接]
樓主: TUMOR
51#
發(fā)表于 2025-3-30 11:41:46 | 只看該作者
52#
發(fā)表于 2025-3-30 15:48:31 | 只看該作者
53#
發(fā)表于 2025-3-30 20:13:41 | 只看該作者
https://doi.org/10.1007/978-94-009-0793-5poor prognosis with a median overall survival time of only 9–15 months. The infiltrating nature of the tumour cells, inter- and intra-tumoral molecular heterogeneity and the tumour’s propensity to hide behind the blood-brain barrier are the key causes of the insufficiency of the optimal available tr
54#
發(fā)表于 2025-3-30 21:51:29 | 只看該作者
55#
發(fā)表于 2025-3-31 01:35:06 | 只看該作者
International Corporate Brand Managementand survival. Targeted cancer therapeutics are amongst the major treatment options for cancer today. These treatments are more selective for cancer cells and improve the quality of life for cancer patients undergoing therapy. Nevertheless, cardiotoxicity is a frequent side effect in targeted therapi
56#
發(fā)表于 2025-3-31 05:36:43 | 只看該作者
57#
發(fā)表于 2025-3-31 09:41:23 | 只看該作者
https://doi.org/10.1007/978-3-658-00406-4heir scientific basis, further aspects are important for new medical procedures to be introduced into broad clinical care. In this matter, we in Germany have special experiences with PET which is still not fully recognized by statutory health insurances as the standard procedure of choice for many i
58#
發(fā)表于 2025-3-31 14:44:36 | 只看該作者
International Courts and Mass Atrocity(theranostics) of prostate cancer, particularly in the metastatic castrate-resistant state. Numerous investigations from around the world in both academic and pharma settings are focused on research and development of safe and effective PSMA-based theranostic agents. Encouraging results from retrosp
59#
發(fā)表于 2025-3-31 19:42:35 | 只看該作者
Understandings of Law in Croatia, 1980s and ended up with radiomolecular precision oncology in 2020s. The author also had own interests which Richard Baum did not touch. The author worked some time with oligonucleotide radionuclide therapy (radionanotargeting) in the 1990s learning that it will be impossible in clinical practice. O
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-9 05:48
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
望城县| 襄汾县| 桓仁| 商洛市| 连云港市| 凤凰县| 温宿县| 三原县| 绍兴县| 湘阴县| 鲁甸县| 山东| 宜阳县| 天峨县| 乐山市| 灌阳县| 汉寿县| 杨浦区| 郎溪县| 诸城市| 佳木斯市| 将乐县| 永登县| 龙南县| 拜泉县| 西藏| 梓潼县| 五莲县| 论坛| 沁阳市| 枣强县| 衡东县| 兴安盟| 资中县| 铜川市| 阜宁县| 浦北县| 永寿县| 萨迦县| 秦安县| 伊金霍洛旗|